What is Abbott Laboratories Quarterly Revenue?

Abbott Laboratories Quarterly Revenue Abbott Jun-2026 Quarterly Revenue is $12,593 Million which is growth of 13.0% YoY.

What is Abbott Laboratories Quarterly Net Profit?

Abbott Laboratories Quarterly Net Profit Abbott Jun-2026 Quarterly Net Profit is $928 Million which is growth of -47.8% YoY.

What is Abbott Laboratories Annual Revenue?

Abbott Laboratories Annual Revenue Abbott Dec-2025 Annual Revenue is $44,328 Million which is growth of 5.7% YoY.

What is Abbott Laboratories Annual Net Profit?

Abbott Laboratories Annual Net Profit Abbott Dec-2025 Annual Net Profit is $6,524 Million which is growth of -51.3% YoY.

What is Abbott Laboratories Total Shareholders Fund?

Abbott Laboratories Total Shareholders Fund Abbott Dec-2025 Total Shareholders Fund is $52,130 Million which is growth of 9.4% YoY.

What is Abbott Laboratories Total Assets?

Abbott Laboratories Total Assets Abbott Dec-2025 Total Assets is $86,713 Million which is growth of 6.5% YoY.

What is Abbott Laboratories Book Value Per Share?

Abbott Laboratories Book Value Per Share Abbott Book Value Per Share is $30 which is growth of 1.7% YoY.

What is Abbott Laboratories ROE?

Abbott Laboratories ROE Abbott ROE is 0% which is growth of 0% YoY.

What is Abbott Laboratories Cash From Operating Activity?

Abbott Laboratories Cash From Operating Activity Abbott Dec-2025 Cash From Operating Activity is $9,566 Million which is growth of 11.8% YoY.

What is Abbott Laboratories Net Cash Flow?

Abbott Laboratories Net Cash Flow Abbott Dec-2025 Net Cash Flow is $835 Million which is growth of 2.3% YoY.

Abbott Laboratories

XNYS: ABT

Await Turnaround

Download real time

2.60(2.67%)

25.98% Fall from 52W High

12.0M

XNYS Volume

XNYS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Dividend

Abbott has an upcoming dividend of $0.630 per share due on 15 Oct 2026See details

Abbott quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Abbott share price target, revenues, EPS, net income and more

Abbott quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Abbott Jun-2026 Quarterly Revenue is $12,593 Million which is growth of 13.0% YoY.
NEGATIVE
Quarterly Net Profit Abbott Jun-2026 Quarterly Net Profit is $928 Million which is growth of -47.8% YoY.

Abbott Laboratories, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	12,593	11,164	11,459	11,369	11,142	10,358	10,974	10,635	10,377	9,964	10,241	10,143	9,978
CostOfRevenue_Q Cost Of Rev.	5,325	4,890	4,922	5,075	4,854	4,468	4,942	4,698	4,603	4,463	4,556	4,605	4,483
GrossProfit_Q Gross Profit	7,268	6,274	6,537	6,294	6,288	5,890	6,032	5,937	5,774	5,501	5,685	5,538	5,495
OEXPNS_Q Operating Exp. ⌄	5,575	4,929	4,286	4,237	4,236	4,197	4,121	4,078	4,105	4,115	3,905	3,891	3,953
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	4,025	3,740	3,129	3,051	3,091	3,061	2,907	2,895	2,936	2,959	2,724	2,723	2,740
ResearchAndDevlopmentExpenses_Q RnD Exp.	892	767	735	766	725	716	749	713	698	684	700	672	715
OP_Q Operating Profit	1,693	1,345	2,251	2,057	2,052	1,693	1,911	1,859	1,669	1,386	1,780	1,647	1,542
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-299	-68	-42	-44	-50	-49	-45	-51	-58	-61	-70	-69	-61
Others_Q Other Interest Earned	52	106	78	77	71	82	91	91	82	80	89	97	98
IntExpNonOperating_Q Interest Exp. Non Operating	351	174	120	121	121	131	136	142	140	141	159	166	159
PBT_Q Profit Before Tax	1,524	1,449	2,358	2,180	2,150	1,778	2,030	1,940	1,607	1,436	1,795	1,671	1,636
TAX_Q Tax	596	372	582	536	371	453	-7,199	294	305	211	201	235	261
NICommonStockholders_Q Net Income Common Stockholders ⌄	928	1,077	1,776	1,644	1,779	1,325	9,229	1,646	1,302	1,225	1,594	1,436	1,375
NP_Q Net Profit	928	1,077	1,776	1,644	1,779	1,325	9,229	1,646	1,302	1,225	1,594	1,436	1,375
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	928	1,077	1,776	1,644	1,779	1,325	9,229	1,646	1,302	1,225	1,594	1,436	1,375
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	928	1,077	1,776	1,644	1,779	1,325	9,229	1,646	1,302	1,225	1,594	1,436	1,375
EPS_Q Basic EPS	0.5	0.6	1	0.9	1	0.8	5.3	0.9	0.7	0.7	0.9	0.8	0.8
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.5	0.6	1	0.9	1	0.8	5.3	0.9	0.7	0.7	0.9	0.8	0.8
SHARE_Q Number Of Shares End	1,740.4	1,742.5	1,739.2	1,742.1	1,743.4	1,739.2	1,737.4	1,739.5	1,743	1,740.2	1,739.2	1,738.7	1,740.4
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	928	1,077	1,776	1,644	1,779	1,325	9,229	1,646	1,302	1,225	1,594	1,436	1,375
NormalizedIncome_Q Normalized Income	930.4	1,067.3	1,764.7	1,631.2	1,769.9	1,319.8	9,221.6	1,636.7	1,297.1	1,225	1,615.3	1,427.4	1,392.7
InterestIncome_Q Interest Income	52	106	78	77	71	82	91	91	82	80	89	97	98
INT_Q Interest	351	174	120	121	121	131	136	142	140	141	159	166	159
NetInterestIncome_Q Net Interest Income	-299	-68	-42	-44	-50	-49	-45	-51	-58	-61	-70	-69	-61
EBIT_Q EBIT	1,875	1,623	2,478	2,301	2,271	1,909	2,166	2,082	1,747	1,577	1,954	1,837	1,795
EBITDA_Q EBITDA	2,935	2,426	3,270	3,092	3,048	2,665	2,973	2,883	2,552	2,382	2,767	2,661	2,595
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	4,923	4,509	4,552	4,704	4,497	4,132	4,600	4,367	4,269	4,130	4,224	4,277	4,181
ReconciledDepreciation_Q Reconciled Depr.	1,060	803	792	791	777	756	807	801	805	805	813	824	800
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	928	1,077	1,776	1,644	1,779	1,325	9,229	1,646	1,302	1,225	1,594	1,436	1,375
NormalizedEBITDA_Q Normalized EBITDA	2,939	2,413	3,255	3,075	3,037	2,658	2,963	2,872	2,546	2,382	2,791	2,651	2,616

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Abbott competitor comparison and performance snapshot within industry

Abbott annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Abbott Dec-2025 Annual Revenue is $44,328 Million which is growth of 5.7% YoY.
NEGATIVE
Annual Net Profit Abbott Dec-2025 Annual Net Profit is $6,524 Million which is growth of -51.3% YoY.

Abbott Laboratories, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
SR_A Total Rev. Ann. ⌄	0.5%	5.1%		44,328	41,950	40,109	43,653	43,075	34,608	31,904	30,578	27,390	20,853	20,405
TotalOperatingRevenues_A Operating Rev. Ann.	0.5%	5.1%	46,585	44,328	41,950	40,109	43,653	43,075	34,608	31,904	30,578	27,390	20,853	20,405
CostOfRevenue_A Cost Of Rev. Ann.	0.3%	5.2%	20,212	19,319	18,706	17,975	19,142	18,537	15,003	13,231	12,706	12,337	9,024	8,747
GrossProfit_A Gross Profit Ann.	0.7%	5%	26,373	25,009	23,244	22,134	24,511	24,538	19,605	18,673	17,872	15,053	11,829	11,658
OEXPNS_A Operating Exp. Ann.	1.6%	3.5%	19,027	16,956	16,419	15,656	16,149	16,113	14,248	14,141	14,222	13,327	8,644	8,791
OP_A Operating Profit Ann.	-1.2%	8.5%	7,346	8,053	6,825	6,478	8,362	8,425	5,357	4,532	3,650	1,726	3,185	2,867
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-453	-185	-215	-252	-375	-490	-500	-576	-721	-780	-332	-58
Others_A Other Interest Earned Ann.	19%	46.3%	313	308	344	385	183	43	46	94	105	124	99	105
IntExpNonOperating_A Interest Exp. Non Operating Ann.	-4%	-2%	766	493	559	637	558	533	546	670	826	904	431	163
OtherExpenses_A Other Exp. Ann.	23.3%	40%		598	403	438	319	276	111	121	-56	1,285	-1,440	374
PBT_A PBT Ann.	0.6%	11.2%	7,511	8,466	7,013	6,664	8,306	8,211	4,968	4,077	2,873	2,231	1,413	3,183
TAX_A Tax Ann.	12.3%	31.3%	2,086	1,942	-6,389	941	1,373	1,140	497	390	539	1,878	350	577
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-2%	7.7%	5,425	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,400	4,423
NP_A Net Profit Ann.	-2%	7.7%	5,425	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,400	4,423
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-2%	7.7%	5,425	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,400	4,423
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-2%	7.7%	5,425	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,400	4,423
EPS_A EPS Ann.	-1.7%	8.2%		3.7	7.7	3.3	3.9	4	2.5	2.1	1.3	0.3	0.9	2.9
DilutedEPS_A Diluted EPS Ann.	-1.7%	8.2%		3.7	7.6	3.3	3.9	3.9	2.5	2.1	1.3	0.3	0.9	2.9
SHARE_Q Number Of Shares End	-0.1%	-0.4%		1,739.2	1,737.4	1,739.2	1,743.4	1,769.4	1,775.5	1,768	1,761	1,748.1	1,479	1,487.3
TotalExpenses_A Total Exp. Ann.	0.9%	4.4%		36,275	35,125	33,631	35,291	34,650	29,251	27,372	26,928	25,664	17,668	17,538
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-2%	7.7%	5,425	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,400	4,423
NormalizedIncome_A Normalized Income Ann.	-2.2%	7.8%	5,393.7	6,485.5	13,381.9	5,758.2	6,934.7	7,071.9	4,463.8	3,750.3	2,492.3	332.6	1,435.2	2,529.8
InterestIncome_A Interest Income Ann.	19%	46.3%	313	308	344	385	183	43	46	94	105	124	99	105
INT_A Interest Ann.	-4%	-2%	766	493	559	637	558	533	546	670	826	904	431	163
EBITDA_A EBITDA Ann.	-0.2%	6.4%	11,723	12,075	10,790	10,544	12,131	12,282	8,841	7,761	6,977	6,156	3,197	4,818
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	0%	5.3%	18,688	17,885	17,366	16,698	17,888	17,046	13,808	12,153	11,606	11,291	8,221	7,876
ReconciledDepreciation_A Reconciled Depr. Ann.	-1.6%	-1.3%	3,446	3,116	3,218	3,243	3,267	3,538	3,327	3,014	3,278	3,021	1,353	1,472
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-2%	7.7%	5,425	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,375	1,583
NormalizedEBITDA_A Normalized EBITDA Ann.	-0.3%	6.4%	11,682	12,025	10,763	10,585	12,133	12,283	8,833	7,831	7,172	6,122	3,692	4,725

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

5.7%

2Y CAGR

5.1%

3Y CAGR

0.5%

5Y CAGR

5.1%

7Y CAGR

5.4%

10Y CAGR

8.1%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

-51.3%

2Y CAGR

6.8%

3Y CAGR

-2%

5Y CAGR

7.7%

7Y CAGR

15.6%

10Y CAGR

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

3.3%

2Y CAGR

4.1%

3Y CAGR

1.6%

5Y CAGR

3.5%

7Y CAGR

2.5%

10Y CAGR

6.8%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Abbott balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Abbott Dec-2025 Total Shareholders Fund is $52,130 Million which is growth of 9.4% YoY.
POSITIVE
Total Assets Abbott Dec-2025 Total Assets is $86,713 Million which is growth of 6.5% YoY.

Abbott Laboratories, Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
TA_A Total Assets Ann. ⌄	5.2%	3.6%	86,713	81,414	73,214	74,438	75,196	72,548	67,887	67,173	76,250	52,666	41,247
CA_A Total Current Assets Ann.	1%	4.9%	25,996	23,656	22,670	25,224	24,239	20,441	15,667	14,632	20,147	26,776	14,155
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	-4.2%	4.6%	8,939	7,967	7,279	10,170	10,249	7,148	4,140	4,086	9,610	18,775	6,125
Receivables_A Change In Account Receivables Ann.	6%	5%	10,569	9,495	8,821	8,881	8,833	8,281	7,211	6,741	6,916	5,054	5,326
Inventories_A Inventories Ann.	1.7%	5.3%	6,488	6,194	6,570	6,173	5,157	5,012	4,316	3,796	3,601	2,434	2,599
OtherCurrentAssets_A Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentAssets_A Total Non Current Assets Ann.	7.3%	3.1%	60,717	57,758	50,544	49,214	50,957	52,107	52,220	52,541	56,103	25,890	27,092
NetPPE_A Net PPE Ann.	8.8%	5.5%	11,816	10,658	10,154	9,162	8,959	9,029	8,038	7,563	7,607	5,705	5,730
InvestmentsAndAdvances_A Investments & Advances Ann.	6.2%	2.3%	918	886	799	766	816	821	883	897	883	2,947	4,041
OtherNonCurrentAssets_A Other Non Current Assets Ann.	45.1%	37.6%	18,422	16,459	7,097	6,033	5,212	3,729	3,079	1,885	2,120	5,016	2,121
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	-3.3%	-3%	33,942	33,513	34,387	37,533	39,172	39,545	36,586	36,451	45,152	31,949	19,921
CL_A Total Current Liabilities Ann.	2.1%	6.7%	16,496	14,157	13,841	15,489	13,105	11,907	10,863	9,012	8,912	6,660	9,186
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	0.6%	2.9%	13,463	12,657	12,761	13,238	12,351	11,687	9,385	8,805	8,198	5,090	5,683
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	10.4%	69%	3,033	1,500	1,080	2,251	754	220	1,478	207	714	1,325	3,130
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	245	373
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	-7.5%	-8.8%	17,446	19,356	20,546	22,044	26,067	27,638	25,723	27,439	36,240	25,289	10,735
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-11.2%	-11%	10,827	13,521	14,548	15,465	18,252	19,429	17,416	19,359	27,210	20,681	5,871
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	1,397	1,070	-	-	-	-	-	-	-	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	12.4%	9.7%	52,130	47,664	38,603	36,686	35,802	32,784	31,088	30,524	30,897	20,538	21,211
EQCAP_A Equity Share Capital Ann.	12.4%	9.7%	52,130	47,664	38,603	36,686	35,802	32,784	31,088	30,524	30,897	20,538	21,211
CapitalStock_A Capital Stock Ann.	1.1%	1.1%	25,527	25,153	24,869	24,709	24,470	24,145	23,853	23,512	23,206	13,027	12,734
RetainedEarnings_A Retained Earnings Ann.	12.2%	12.5%	49,781	47,261	37,554	35,257	31,528	27,627	25,847	24,560	23,978	25,565	25,757
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-6,001	-7,906	-7,839	-8,051	-8,374	-8,946	-8,465	-7,586	-6,062	-7,263	-6,658
TotalCapitalization_A Total Capitalization Ann.	6.6%	3.9%	62,026	60,289	52,202	51,208	53,098	51,311	47,749	49,883	58,107	41,219	27,082
TangibleAssets_A Tangible Assets Ann.	87.3%	-	22,569	17,909	6,109	3,433	-168	-5,744	-9,132	-11,672	-14,596	8,316	6,011
WC_A Working Capital Ann.	-0.8%	2.2%	9,500	9,499	8,829	9,735	11,134	8,534	4,804	5,620	11,235	20,116	4,969
InvestedCapital_A Invested Capital Ann.	6.8%	4.8%	65,059	61,789	53,282	53,459	53,852	51,531	49,227	50,090	58,821	42,544	30,212
TangibleBookValue_A Tangible Book Value Ann.	87.3%	-	22,569	17,909	6,109	3,433	-168	-5,744	-9,132	-11,672	-14,596	8,316	6,011
Borrowings_A Borrowings Ann.	-7.9%	-6.7%	13,860	15,021	15,628	17,716	19,006	19,649	18,894	19,566	27,924	22,006	9,001
NetDebt_A Net Debt Ann.	-13.8%	-18%	4,407	6,509	7,783	6,891	8,251	11,909	14,279	15,722	18,517	3,386	4,000
ShareIssued_A Share Issued Ann.	0.2%	0.2%	1,996.8	1,991.5	1,987.9	1,986.5	1,985.3	1,981.2	1,976.9	1,971.2	1,965.9	1,707.5	1,702
SHARE_Q Number Of Shares End	-0.1%	-0.4%	1,739.2	1,737.4	1,739.2	1,743.4	1,769.4	1,775.5	1,768	1,761	1,748.1	1,479	1,487.3

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

6.5%

2Y CAGR

8.8%

3Y CAGR

5.2%

5Y CAGR

3.6%

7Y CAGR

3.7%

10Y CAGR

7.7%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

16.5%

2Y CAGR

9.2%

3Y CAGR

2.1%

5Y CAGR

6.7%

7Y CAGR

10Y CAGR

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

9.4%

2Y CAGR

16.2%

3Y CAGR

12.4%

5Y CAGR

9.7%

7Y CAGR

7.9%

10Y CAGR

9.4%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Abbott ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Abbott Book Value Per Share is $30 which is growth of 1.7% YoY.
NEUTRAL
ROE Abbott ROE is 0% which is growth of 0% YoY.

Abbott Laboratories, Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
ROA_A RoA Ann. %	-	-	-	17.33%	7.75%	9.27%	9.57%	6.40%	5.46%	3.30%	0.74%	2.98%	10.72%
ROE_A ROE Ann. %	-	-	-	31.07%	15.20%	19.13%	20.62%	14.08%	11.97%	7.71%	1.85%	6.71%	20.70%
ROIC_Q ROIC %	-	-	-	15.8	3.1	2	3.9	4.5	2.3	1.5	-1.2	2.5	2.6
OPMPCT_A OPM Ann. %	-1.8%	3.3%	18.17%	16.27%	16.15%	19.16%	19.56%	15.48%	14.21%	11.94%	6.30%	15.27%	14.05%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	2.9	2.8	3.4	3.7	3.2	3.3	3.4	4.1	3.6	3.3
ASETTO_A Asset Turnover Ann. %	-	-	-	0.5	0.5	0.6	0.6	0.5	0.5	0.4	0.4	0.4	0.5
WCTO_A Working Capital Turnover Ann.	1.5%	2.8%	4.7	4.4	4.5	4.5	3.9	4.1	6.6	5.4	2.4	1	4.1
QuickRatio_A Quick Ratio Ann.	-	-	-	1.2	1.2	1.2	1.5	1.3	1	1.2	1.9	3.6	1.3
CRATIO_A Current Ratio Ann.	-	-	-	1.7	1.6	1.6	1.9	1.7	1.4	1.6	2.3	4	1.5
IC_A Interest Coverage Ratio Ann.	-	-	-	13.6	11.5	15.9	16.4	10.1	7.1	4.5	3.5	4.3	20.5
LTDE_A LT Debt To Equity Ann.	-	-	-	0.3	0.4	0.4	0.5	0.6	0.6	0.6	0.9	1	0.3

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Abbott cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Abbott Dec-2025 Cash From Operating Activity is $9,566 Million which is growth of 11.8% YoY.
POSITIVE
Net Cash Flow Abbott Dec-2025 Net Cash Flow is $835 Million which is growth of 2.3% YoY.

Abbott Laboratories, Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
CFO_A Cash from Operating Act. Ann. ⌄	-0.1%	3.9%	9,566	8,558	7,261	9,581	10,533	7,901	6,136	6,300	5,570	3,203	2,966
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-2%	7.7%	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,375	1,583
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-1.6%	-1.3%	3,116	3,218	3,243	3,267	3,538	3,327	3,014	3,278	3,021	1,353	1,472
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-1.6%	-1.3%	3,116	3,218	3,243	3,267	3,538	3,327	3,014	3,278	3,021	1,353	1,472
DeferredTax_A Deferred Tax Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
EmployeesStockOptions_A ESOPs Ann.	-1%	4%	664	673	644	685	640	546	519	477	406	310	292
OtherNonCashItems_A Other Non Cash Items Ann.	-	-	-	-	-	-	-	-	-	32	912	165	-
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-803	-9,217	-2,475	-1,519	-771	-892	-1,331	-148	1,915	-1,513	-156
ChangeInReceivables_A Change In Receivables Ann.	-	-	-652	-691	-356	-68	-383	-924	-275	-190	-207	-177	-171
ChangeInInventory_A Change In Inventory Ann.	-	-	195	-58	-232	-1,413	-456	-493	-593	-514	249	-98	-257
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	194.9%	-3.8%	949	-7,672	-760	37	380	1,152	-325	533	1,764	-1,351	215
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-	-	-585	-	-	-	-	-	-	-	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-2,422	-2,338	-3,133	-1,740	-2,008	-2,215	-1,815	-1,356	-9,618	-248	406
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-2,171	-2,207	-2,202	-1,777	-1,885	-2,177	-1,638	-1,394	-1,135	-1,121	-1,110
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-2,171	-2,207	-2,202	-1,777	-1,885	-2,177	-1,638	-1,394	-1,135	-1,121	-1,110
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-105	1	-837	48	-53	16	-122	48	-8,437	-55	2,285
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-105		-877		-187	-42	-170		-17,183	-80	-235
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-167	-169	-159	-185	-173	-83	-103	-131	-210	-2,823	-4,933
SaleOfInvestment_A Sale Of Investment Ann.	-73%	-21.4%	3	28	43	152	77	10	21	73	129	3,709	4,112
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-6.5%	-1.1%	18	9	22	22	26	19	27	48	35	42	52
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-6,309	-5,404	-7,091	-7,636	-5,494	-2,779	-4,289	-10,391	-5,281	11,147	-2,236
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-1,614	-537	-2,475	-699	-248	-50	-1,599	-8,450	-2,942	13,155	1,147
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-1,499	-437	-2,496	-746	-44	-52	-1,599	-8,424	-1,908	14,922	2,428
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-115	-100	21	47	-204	2		-26	-1,034	-1,767	-1,281
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-893	-1,295	-1,227	-3,795	-2,299	-403	-718	-238	-117	-522	-2,237
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-893	-1,295	-1,227	-3,795	-2,299	-403	-718	-238	-117	-522	-2,237
dividend_1Y_actual Dividend 1year	8.1%	11.4%	2.4	2.2	2	1.9	1.8	1.4	1.3	1.1	1	1	1
DividendPerShare_A Dividend Per Share Ann.	-	-	-4,116	-3,836	-3,556	-3,309	-3,202	-2,560	-2,270	-1,974	-1,849	-1,539	-1,443
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-82	-	-	-	-	-11	-	-	-13	-195	-17
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-4.8%	4.5%	8,522	7,616	6,896	9,882	9,799	6,838	3,860	3,844	9,407	18,620	5,001
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	59.7%	-22.1%	835	816	-2,963	205	3,031	2,907	32	-5,447	-9,329	14,102	1,136
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-8.1%	14.6%	7,616	6,896	9,882	9,799	6,838	3,860	3,844	9,407	18,620	5,001	4,063
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	1.2%	14.8%	1,933	1,723	1,475	1,864	1,941	970	930	740	570	620	631
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-1.1%	-0.1%	545	604	662	563	544	549	677	845	917	181	166
CapitalExpenditure_A Capex Ann.	-	-	-2,171	-2,207	-2,202	-1,777	-1,885	-2,177	-1,638	-1,394	-1,135	-1,121	-1,110
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	-10.6%	-67%	5	223	2	7	4	1,281	1,842	4,009	6,742	14,934	2,485
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-1,504	-660	-2,498	-753	-48	-1,333	-3,441	-12,433	-8,650	-12	-57
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-893	-1,295	-1,227	-3,795	-2,299	-403	-718	-238	-827	-522	-2,237
FreeCashFlow_A Free Cash Flow Ann.	-1.8%	5.3%	7,395	6,351	5,059	7,804	8,648	5,724	4,498	4,906	4,435	2,082	1,856

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

11.8%

2Y CAGR

14.8%

3Y CAGR

-0.1%

5Y CAGR

3.9%

7Y CAGR

6.1%

10Y CAGR

12.4%

Cash from Operating Activity Annual growth is higher than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

25.98% Fall from 52W High

Abbott quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Abbott - Forecaster

Forecaster Analyst Estimates for Abbott share price target, revenues, EPS, net income and more

Abbott - Earnings Report - Quarterly Results

Abbott quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Abbott Jun-2026 Quarterly Revenue is $12,593 Million which is growth of 13.0% YoY.

Quarterly Net Profit Abbott Jun-2026 Quarterly Net Profit is $928 Million which is growth of -47.8% YoY.

Abbott - Competitors/Peers

Abbott competitor comparison and performance snapshot within industry

Abbott - Earnings Report - Annual Results

Abbott annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue Abbott Dec-2025 Annual Revenue is $44,328 Million which is growth of 5.7% YoY.

Annual Net Profit Abbott Dec-2025 Annual Net Profit is $6,524 Million which is growth of -51.3% YoY.

Abbott - Balance Sheet

Abbott balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Abbott Dec-2025 Total Shareholders Fund is $52,130 Million which is growth of 9.4% YoY.

Total Assets Abbott Dec-2025 Total Assets is $86,713 Million which is growth of 6.5% YoY.

Abbott - Ratios

Abbott ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share Abbott Book Value Per Share is $30 which is growth of 1.7% YoY.

ROE Abbott ROE is 0% which is growth of 0% YoY.

Abbott - Cash Flow

Abbott cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity Abbott Dec-2025 Cash From Operating Activity is $9,566 Million which is growth of 11.8% YoY.

Net Cash Flow Abbott Dec-2025 Net Cash Flow is $835 Million which is growth of 2.3% YoY.